MetaADEDB 2.0 @ LMMD
Lurasidone Hydrochloride
(NEKCRUIRPWNMLK-SCIYSFAVSA-N)
Structure
SMILES
O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1.Cl
Molecular Formula:
C28H37ClN4O2S
Molecular Weight:
529.137
Log P:
4.9986
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
84.99
CAS Number(s):
367514-88-3; 1132654-54-6
Synonym(s)
1.
Lurasidone Hydrochloride
2.
Latuda
3.
Lurasidone
4.
Lurasidone HCl
5.
N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide
6.
SM 13496
7.
SM-13,496
8.
SM-13496
9.
SM13496
10.
13496, SM
11.
HCl, Lurasidone
12.
Hydrochloride, Lurasidone
13.
SM 13,496
14.
SM13,496
External Link(s)
MeSHD000069056
PubChem Compound11237860
139083514
ChEBI70732
CHEMBLCHEMBL1615372
KEGGdr:D04820
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 257US FAERS
2Feeling abnormalFAERS: 254US FAERS
3SomnolenceFAERS: 222US FAERS
4AnxietyFAERS: 216US FAERS
5NauseaFAERS: 187US FAERS
6FatigueFAERS: 176
Canada Vigilance: 1
Canada Vigilance
US FAERS
7AkathisiaFAERS: 149US FAERS
8RestlessnessFAERS: 147
Canada Vigilance: 1
Canada Vigilance
US FAERS
9Tardive DyskinesiaFAERS: 126
Canada Vigilance: 2
Canada Vigilance
US FAERS
10TremorFAERS: 120US FAERS
11VomitingFAERS: 119US FAERS
12MalaiseFAERS: 96US FAERS
13HeadacheFAERS: 91US FAERS
14Product dose omissionFAERS: 78US FAERS
15AgitationFAERS: 74US FAERS
16DizzinessFAERS: 70
Canada Vigilance: 1
Canada Vigilance
US FAERS
17Weight decreasedFAERS: 70US FAERS
18Drug administration errorFAERS: 69US FAERS
19Depressed moodFAERS: 65US FAERS
20AngerFAERS: 64US FAERS
21Drug dose omissionFAERS: 63US FAERS
22Bipolar DisorderFAERS: 57US FAERS
23PainFAERS: 47US FAERS
24CryingFAERS: 46US FAERS
25HypersensitivityFAERS: 46US FAERS
26DystoniaFAERS: 45US FAERS
27Blood glucose increasedFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Memory impairmentFAERS: 41US FAERS
29AstheniaFAERS: 40US FAERS
30Suicide attemptFAERS: 40US FAERS
31UrticariaFAERS: 40US FAERS
32Drug ineffective for unapproved indicationFAERS: 39US FAERS
33Restless Legs SyndromeFAERS: 37US FAERS
34PregnancyFAERS: 36US FAERS
35Musculoskeletal stiffnessFAERS: 35US FAERS
36HypersomniaFAERS: 34US FAERS
37PruritusFAERS: 34US FAERS
38Blood prolactin increasedFAERS: 33US FAERS
39ParanoiaFAERS: 31US FAERS
40Abdominal discomfortFAERS: 30US FAERS
41BruxismFAERS: 30US FAERS
42PalpitationsFAERS: 30US FAERS
43Wrong technique in product usage processFAERS: 29US FAERS
44Mood swingsFAERS: 27US FAERS
45SchizophreniaFAERS: 26US FAERS
46Completed SuicideFAERS: 25US FAERS
47StressFAERS: 24US FAERS
48ApathyFAERS: 21US FAERS
49Product administration errorFAERS: 21US FAERS
50TrismusFAERS: 21US FAERS
51AmnesiaFAERS: 20US FAERS
52Chest PainFAERS: 20US FAERS
53Emotional disorderFAERS: 20US FAERS
54Maternal exposure during pregnancyFAERS: 20US FAERS
55OverdoseFAERS: 20US FAERS
56Cerebrovascular accidentFAERS: 19US FAERS
57ChillsFAERS: 18US FAERS
58HypomaniaFAERS: 18US FAERS
59Intentional self-injuryFAERS: 18US FAERS
60NervousnessFAERS: 18US FAERS
61Feeling jitteryFAERS: 17US FAERS
62Emotional povertyFAERS: 16US FAERS
63Activation syndromeFAERS: 15US FAERS
64AlopeciaFAERS: 15US FAERS
65Drug withdrawal syndromeFAERS: 15US FAERS
66Middle insomniaFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
67Therapeutic response unexpectedFAERS: 15US FAERS
68Back PainFAERS: 14US FAERS
69DiscomfortFAERS: 14US FAERS
70DroolingFAERS: 14US FAERS
71DysgeusiaFAERS: 14US FAERS
72MyalgiaFAERS: 14US FAERS
73Neuroleptic Malignant SyndromeFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
74Visual ImpairmentFAERS: 14US FAERS
75BlepharospasmFAERS: 13US FAERS
76Emotional distressFAERS: 13US FAERS
77HungerFAERS: 13US FAERS
78Lip swellingFAERS: 13US FAERS
79Muscle tightnessFAERS: 13US FAERS
80AngioedemaFAERS: 12US FAERS
81Chest discomfortFAERS: 12US FAERS
82ConstipationFAERS: 12US FAERS
83DysarthriaFAERS: 12US FAERS
84Euphoric moodFAERS: 12US FAERS
85Muscle RigidityFAERS: 12US FAERS
86Myocardial InfarctionFAERS: 12US FAERS
87NasopharyngitisFAERS: 12US FAERS
88Bipolar I disorderFAERS: 11US FAERS
89Blood triglycerides increasedFAERS: 11US FAERS
90ErythemaFAERS: 11US FAERS
91Incorrect dose administeredFAERS: 11US FAERS
92LethargyFAERS: 11US FAERS
93Peripheral swellingFAERS: 11US FAERS
94Abdominal PainFAERS: 10US FAERS
95AphasiaFAERS: 10US FAERS
96Erectile dysfunctionFAERS: 10US FAERS
97Flat affectFAERS: 10US FAERS
98Negative thoughtsFAERS: 10US FAERS
99Obsessive-Compulsive DisorderFAERS: 10US FAERS
100TachyphreniaFAERS: 10US FAERS
101ArthralgiaFAERS: 9US FAERS
102Blood cholesterol increasedFAERS: 9US FAERS
103Diabetes MellitusFAERS: 9US FAERS
104EnuresisFAERS: 9US FAERS
105Neck PainFAERS: 9US FAERS
106Oromandibular dystoniaFAERS: 9US FAERS
107Poor quality sleepFAERS: 9US FAERS
108Sexual DysfunctionFAERS: 9US FAERS
109TachycardiaFAERS: 9US FAERS
110Therapy cessationFAERS: 9US FAERS
111ThirstFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
112White blood cell count decreasedFAERS: 9US FAERS
113CatatoniaFAERS: 8US FAERS
114FormicationFAERS: 8US FAERS
115Gastric BypassFAERS: 8US FAERS
116HypotensionFAERS: 8US FAERS
117Personality ChangeFAERS: 8US FAERS
118PneumoniaFAERS: 8US FAERS
119Psychotic symptomFAERS: 8US FAERS
120ScreamingFAERS: 8US FAERS
121ThrombocytopeniaFAERS: 8US FAERS
122Tongue movement disturbanceFAERS: 8US FAERS
123Violence-related symptomFAERS: 8US FAERS
124DehydrationFAERS: 7US FAERS
125DisorientationFAERS: 7US FAERS
126Feeling ColdFAERS: 7US FAERS
127FlushingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
128Food cravingFAERS: 7US FAERS
129Gait inabilityFAERS: 7US FAERS
130Product use in unapproved indicationFAERS: 7US FAERS
131Psychiatric decompensationFAERS: 7US FAERS
132Schizoaffective DisorderFAERS: 7US FAERS
133SomnambulismFAERS: 7US FAERS
134AbasiaFAERS: 6US FAERS
135AcneFAERS: 6US FAERS
136Blood creatinine increasedFAERS: 6US FAERS
137Cerebral disorderFAERS: 6US FAERS
138Deep Vein ThrombosisFAERS: 6US FAERS
139DissociationFAERS: 6US FAERS
140General physical health deteriorationFAERS: 6US FAERS
141Impaired work abilityFAERS: 6US FAERS
142InfluenzaFAERS: 6US FAERS
143Joint stiffnessFAERS: 6US FAERS
144Medication ErrorFAERS: 6US FAERS
145Mental impairmentFAERS: 6US FAERS
146NeutropeniaFAERS: 6US FAERS
147Oropharyngeal painFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
148PancreatitisFAERS: 6US FAERS
149Pulmonary EmbolismFAERS: 6US FAERS
150SyncopeFAERS: 6US FAERS
151TensionFAERS: 6US FAERS
152TinnitusFAERS: 6US FAERS
153AnhedoniaFAERS: 5US FAERS
154Aspartate Aminotransferase IncreasedFAERS: 5US FAERS
155BradyphreniaFAERS: 5US FAERS
156Burning sensationFAERS: 5US FAERS
157ChromaturiaFAERS: 5US FAERS
158Cogwheel RigidityFAERS: 5US FAERS
159Drug abuseFAERS: 5US FAERS
160Drug effect incompleteFAERS: 5US FAERS
161DyspepsiaFAERS: 5US FAERS
162DysuriaFAERS: 5US FAERS
163HostilityFAERS: 5US FAERS
164HypokinesiaFAERS: 5US FAERS
165Oculogyric crisisFAERS: 5US FAERS
166Post-Traumatic Stress DisorderFAERS: 5US FAERS
167Prescribed overdoseFAERS: 5US FAERS
168PresyncopeFAERS: 5US FAERS
169Product use issueFAERS: 5US FAERS
170SneezingFAERS: 5US FAERS
171SwellingFAERS: 5US FAERS
172TorticollisFAERS: 5US FAERS
173Urinary RetentionFAERS: 5US FAERS
174Urinary tract infectionFAERS: 5US FAERS
175VertigoFAERS: 5US FAERS
176Alanine Aminotransferase IncreasedFAERS: 4US FAERS
177Blood creatine phosphokinase increasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
178Cardiac ArrestFAERS: 4US FAERS
179DysphemiaFAERS: 4US FAERS
180Exposure during breast feedingFAERS: 4US FAERS
181FlatulenceFAERS: 4US FAERS
182HypophagiaFAERS: 4US FAERS
183Impaired driving abilityFAERS: 4US FAERS
184IncontinenceFAERS: 4US FAERS
185InfectionFAERS: 4US FAERS
186Initial insomniaFAERS: 4US FAERS
187Joint swellingFAERS: 4US FAERS
188LymphadenopathyFAERS: 4US FAERS
189SoliloquyFAERS: 4US FAERS
190Temperature intoleranceFAERS: 4US FAERS
191ToothacheFAERS: 4US FAERS
192Activities of daily living impairedFAERS: 3US FAERS
193AgranulocytosisFAERS: 3US FAERS
194AkinesiaFAERS: 3US FAERS
195ArthropathyFAERS: 3US FAERS
196Back disorderFAERS: 3US FAERS
197Blood glucose abnormalFAERS: 3US FAERS
198Blood glucose decreasedFAERS: 3US FAERS
199Blood sodium decreasedFAERS: 3US FAERS
200Blunted affectFAERS: 3US FAERS
201ClaustrophobiaFAERS: 3US FAERS
202DiplopiaFAERS: 3US FAERS
203Drug DependenceFAERS: 3US FAERS
204Drug ToleranceFAERS: 3US FAERS
205Drug administered to patient of inappropriate ageFAERS: 3US FAERS
206Dry skinFAERS: 3US FAERS
207DysphoniaFAERS: 3US FAERS
208Excessive eye blinkingFAERS: 3US FAERS
209Eye painFAERS: 3US FAERS
210Feeling of body temperature changeFAERS: 3US FAERS
211Foaming at mouthFAERS: 3US FAERS
212Gestational DiabetesFAERS: 3US FAERS
213Head discomfortFAERS: 3US FAERS
214Head titubationFAERS: 3US FAERS
215HomicideFAERS: 3US FAERS
216HyperphagiaFAERS: 3US FAERS
217Inappropriate schedule of drug administrationFAERS: 3US FAERS
218Intentional product use issueFAERS: 3US FAERS
219Intrusive thoughtsFAERS: 3US FAERS
220LacerationFAERS: 3US FAERS
221Limb discomfortFAERS: 3US FAERS
222Muscle strainFAERS: 3US FAERS
223MyoclonusFAERS: 3US FAERS
224NarcolepsyFAERS: 3US FAERS
225Night sweatsFAERS: 3US FAERS
226ObesityFAERS: 3US FAERS
227Obsessive thoughtsFAERS: 3US FAERS
228PolydipsiaFAERS: 3US FAERS
229Pre-EclampsiaFAERS: 3US FAERS
230Psychiatric symptomFAERS: 3US FAERS
231Rash erythematousFAERS: 3US FAERS
232RetchingFAERS: 3US FAERS
233RhabdomyolysisFAERS: 3US FAERS
234Seizure like phenomenaFAERS: 3US FAERS
235Sleep ParalysisFAERS: 3US FAERS
236Stevens-Johnson SyndromeFAERS: 3US FAERS
237Temperature regulation disorderFAERS: 3US FAERS
238Tension HeadacheFAERS: 3US FAERS
239ThrombosisFAERS: 3US FAERS
240Toxicity to various agentsFAERS: 3US FAERS
241Unresponsive to stimuliFAERS: 3US FAERS
242nervous system disorderFAERS: 3US FAERS
243Accidental overdoseFAERS: 2US FAERS
244Acute kidney injuryFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
245Adverse eventFAERS: 2US FAERS
246AgeusiaFAERS: 2US FAERS
247Anaphylactic shockFAERS: 2US FAERS
248Angina PectorisFAERS: 2US FAERS
249AnorgasmiaFAERS: 2US FAERS
250ArthritisFAERS: 2US FAERS
251Atrial FibrillationFAERS: 2US FAERS
252AutophobiaFAERS: 2US FAERS
253Bipolar II disorderFAERS: 2US FAERS
254BlindnessFAERS: 2US FAERS
255Blood potassium decreasedFAERS: 2US FAERS
256Blood pressure fluctuationFAERS: 2US FAERS
257BoredomFAERS: 2US FAERS
258CellulitisFAERS: 2US FAERS
259ChemotherapyFAERS: 2US FAERS
260ChokingFAERS: 2US FAERS
261CystitisFAERS: 2US FAERS
262DementiaFAERS: 2US FAERS
263Depressed Level of ConsciousnessFAERS: 2US FAERS
264Diet refusalFAERS: 2US FAERS
265DiplegiaFAERS: 2US FAERS
266Eating disorder symptomFAERS: 2US FAERS
267Exposure via breast milkFAERS: 2US FAERS
268Facial ParesisFAERS: 2US FAERS
269Facial paralysisFAERS: 2US FAERS
270Feelings of worthlessnessFAERS: 2US FAERS
271Frustration tolerance decreasedFAERS: 2US FAERS
272GastrectomyFAERS: 2US FAERS
273GingivitisFAERS: 2US FAERS
274Hallucinations, mixedFAERS: 2US FAERS
275HemiparesisFAERS: 2US FAERS
276HepatitisFAERS: 2US FAERS
277HypervigilanceFAERS: 2US FAERS
278Inappropriate schedule of product administrationFAERS: 2US FAERS
279Intention tremorFAERS: 2US FAERS
280Intentional dose omissionFAERS: 2US FAERS
281Intentional product misuseFAERS: 2US FAERS
282LazinessFAERS: 2US FAERS
283LeukopeniaFAERS: 2US FAERS
284Limb injuryFAERS: 2US FAERS
285Low density lipoprotein increasedFAERS: 2US FAERS
286Lyme DiseaseFAERS: 2US FAERS
287Mental status changesFAERS: 2US FAERS
288Morbid thoughtsFAERS: 2US FAERS
289Motion SicknessFAERS: 2US FAERS
290Mouth swellingFAERS: 2US FAERS
291Musculoskeletal PainFAERS: 2US FAERS
292Musculoskeletal discomfortFAERS: 2US FAERS
293Nasal discomfortFAERS: 2US FAERS
294Nerve injuryFAERS: 2US FAERS
295NeuralgiaFAERS: 2US FAERS
296Nuchal RigidityFAERS: 2US FAERS
297Pain of skinFAERS: 2US FAERS
298PancytopeniaFAERS: 2US FAERS
299Panic DisorderFAERS: 2US FAERS
300ParasomniaFAERS: 2US FAERS
301PhotophobiaFAERS: 2US FAERS
302Poor personal hygieneFAERS: 2US FAERS
303Prescribed underdoseFAERS: 2US FAERS
304PriapismFAERS: 2US FAERS
305PsoriasisFAERS: 2US FAERS
306Pulmonary HypertensionFAERS: 2US FAERS
307Rebound effectFAERS: 2US FAERS
308Reduced facial expressionFAERS: 2US FAERS
309Renal painFAERS: 2US FAERS
310Sinus TachycardiaFAERS: 2US FAERS
311Skin reactionFAERS: 2US FAERS
312SluggishnessFAERS: 2US FAERS
313StaringFAERS: 2US FAERS
314StrabismusFAERS: 2US FAERS
315StuporFAERS: 2US FAERS
316Sudden deathFAERS: 2US FAERS
317Suicide threatFAERS: 2US FAERS
318Supraventricular tachycardiaFAERS: 2US FAERS
319Therapeutic product effect incompleteFAERS: 2US FAERS
320Throat irritationFAERS: 2US FAERS
321Tongue bitingFAERS: 2US FAERS
322Tongue spasmFAERS: 2US FAERS
323Unevaluable eventFAERS: 2US FAERS
324Walking aid userFAERS: 2US FAERS
325Abnormal sleep-related eventFAERS: 1US FAERS
326AbuliaFAERS: 1US FAERS
327Accidental exposure to product by childFAERS: 1US FAERS
328Alcohol abuseFAERS: 1US FAERS
329Alcohol interactionFAERS: 1US FAERS
330Alcohol poisoningFAERS: 1US FAERS
331Allergic reaction to excipientFAERS: 1US FAERS
332Ammonia increasedFAERS: 1US FAERS
333Amniotic fluid volume decreasedFAERS: 1US FAERS
334Amphetamines positiveFAERS: 1US FAERS
335Amylase increasedFAERS: 1US FAERS
336Ankle FractureFAERS: 1US FAERS
337AphagiaFAERS: 1US FAERS
338Arthropod stingFAERS: 1US FAERS
339AsthenopiaFAERS: 1US FAERS
340AsthmaFAERS: 1US FAERS
341Benign Prostatic HyperplasiaFAERS: 1US FAERS
342Blood blisterFAERS: 1US FAERS
343Blood creatinine abnormalFAERS: 1US FAERS
344Blood phosphorus decreasedFAERS: 1US FAERS
345Blood potassium increasedFAERS: 1US FAERS
346Blood triglycerides abnormalFAERS: 1US FAERS
347Body temperature fluctuationFAERS: 1US FAERS
348Bone painFAERS: 1US FAERS
349Borderline Personality DisorderFAERS: 1US FAERS
350BradycardiaFAERS: 1US FAERS
351Breast discomfortFAERS: 1US FAERS
352Breast engorgementFAERS: 1US FAERS
353Breast tendernessFAERS: 1US FAERS
354Breech PresentationFAERS: 1US FAERS
355Brief psychotic disorder, with postpartum onsetFAERS: 1US FAERS
356BronchitisFAERS: 1US FAERS
357Butterfly rashFAERS: 1US FAERS
358Cardiometabolic syndromeFAERS: 1US FAERS
359CarotidyniaFAERS: 1US FAERS
360Central nervous system lesionFAERS: 1US FAERS
361Cervix carcinomaFAERS: 1US FAERS
362Change in sustained attentionFAERS: 1US FAERS
363Choking sensationFAERS: 1US FAERS
364CholelithiasisFAERS: 1US FAERS
365CholestasisFAERS: 1US FAERS
366Chronic cheek bitingFAERS: 1US FAERS
367Coagulation test abnormalFAERS: 1US FAERS
368Cold sweatFAERS: 1US FAERS
369Complication of deliveryFAERS: 1US FAERS
370Compulsive shoppingFAERS: 1US FAERS
371Conversion disorderFAERS: 1US FAERS
372Culture urine positiveFAERS: 1US FAERS
373Cyclothymic DisorderFAERS: 1US FAERS
374CystFAERS: 1US FAERS
375Deaf MutismFAERS: 1US FAERS
376Deja VuFAERS: 1US FAERS
377DeliriumFAERS: 1US FAERS
378Delusion of replacementFAERS: 1US FAERS
379Delusional disorder, unspecified typeFAERS: 1US FAERS
380Depression suicidalFAERS: 1US FAERS
381Diabetes InsipidusFAERS: 1US FAERS
382Diabetes mellitus inadequate controlFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
383Diabetic KetoacidosisFAERS: 1US FAERS
384Disease recurrenceFAERS: 1US FAERS
385Dissociative Identity DisorderFAERS: 1US FAERS
386Disturbance in sexual arousalFAERS: 1US FAERS
387Drug dispensing errorFAERS: 1US FAERS
388Drug dispensing issueFAERS: 1US FAERS
389Drug level decreasedFAERS: 1US FAERS
390Drug prescribing errorFAERS: 1US FAERS
391Drug screen false positiveFAERS: 1US FAERS
392Drug screen positiveFAERS: 1US FAERS
393Drug titration errorFAERS: 1US FAERS
394Drug withdrawal headacheFAERS: 1US FAERS
395DyscheziaFAERS: 1US FAERS
396EcchymosisFAERS: 1US FAERS
397Ectopic PregnancyFAERS: 1US FAERS
398EczemaFAERS: 1US FAERS
399Electrocardiogram abnormalFAERS: 1US FAERS
400Enamel anomalyFAERS: 1US FAERS
401EndometriosisFAERS: 1US FAERS
402EpistaxisFAERS: 1US FAERS
403EructationFAERS: 1US FAERS
404ErysipelasFAERS: 1US FAERS
405Executive dysfunctionFAERS: 1US FAERS
406ExophthalmosFAERS: 1US FAERS
407Expired product administeredFAERS: 1US FAERS
408Eye irritationFAERS: 1US FAERS
409Facial PainFAERS: 1US FAERS
410Fear of fallingFAERS: 1US FAERS
411Female Orgasmic DisorderFAERS: 1US FAERS
412Fibrin D dimer increasedFAERS: 1US FAERS
413Flank PainFAERS: 1US FAERS
414Fluid intake restrictionFAERS: 1US FAERS
415Foreign body in respiratory tractFAERS: 1US FAERS
416FrustrationFAERS: 1US FAERS
417Gastric ulcerFAERS: 1US FAERS
418GastritisFAERS: 1US FAERS
419GastroenteritisFAERS: 1US FAERS
420Gastrointestinal PainFAERS: 1US FAERS
421Gastrointestinal carcinomaFAERS: 1US FAERS
422Gastrointestinal motility disorderFAERS: 1US FAERS
423GastrostomyFAERS: 1US FAERS
424General physical condition abnormalFAERS: 1US FAERS
425Genital infectionFAERS: 1US FAERS
426GlaucomaFAERS: 1US FAERS
427Gluten sensitivityFAERS: 1US FAERS
428Grip strength decreasedFAERS: 1US FAERS
429Heat ExhaustionFAERS: 1US FAERS
430HemiplegiaFAERS: 1US FAERS
431Hip surgeryFAERS: 1US FAERS
432HydrocephalusFAERS: 1US FAERS
433HyperacusisFAERS: 1US FAERS
434HyperchlorhydriaFAERS: 1US FAERS
435HypermetabolismFAERS: 1US FAERS
436HyperreflexiaFAERS: 1US FAERS
437Hypertensive crisisFAERS: 1US FAERS
438HypohidrosisFAERS: 1US FAERS
439HypothyroidismFAERS: 1US FAERS
440HysterectomyFAERS: 1US FAERS
441Impaired self-careFAERS: 1US FAERS
442ImpetigoFAERS: 1US FAERS
443IncoherentFAERS: 1US FAERS
444Incorrect product formulation administeredFAERS: 1US FAERS
445Incorrect route of drug administrationFAERS: 1US FAERS
446Infantile apnoeic attackFAERS: 1US FAERS
447InflammationFAERS: 1US FAERS
448Infrequent bowel movementsFAERS: 1US FAERS
449Insulin ResistanceFAERS: 1US FAERS
450Insulin-requiring type 2 diabetes mellitusFAERS: 1US FAERS
451Intercepted wrong patient selectedFAERS: 1US FAERS
452Intestinal ObstructionFAERS: 1US FAERS
453IritisFAERS: 1US FAERS
454Iron deficiencyFAERS: 1US FAERS
455Irregular breathingFAERS: 1US FAERS
456Irregular sleep phaseFAERS: 1US FAERS
457Joint injuryFAERS: 1US FAERS
458KetoacidosisFAERS: 1US FAERS
459Lactation DisorderFAERS: 1US FAERS
460Large intestine perforationFAERS: 1US FAERS
461LaryngospasmFAERS: 1US FAERS
462Libido disorderFAERS: 1US FAERS
463Lipase decreasedFAERS: 1US FAERS
464LipomaFAERS: 1US FAERS
465Long QT SyndromeFAERS: 1US FAERS
466Loose associationsFAERS: 1US FAERS
467Loss of bladder sensationFAERS: 1US FAERS
468Loss of personal independence in daily activitiesFAERS: 1US FAERS
469Lupus-like syndromeFAERS: 1US FAERS
470LymphomaFAERS: 1US FAERS
471MacrocytosisFAERS: 1US FAERS
472MalabsorptionFAERS: 1US FAERS
473Male Orgasmic DisorderFAERS: 1US FAERS
474MalnutritionFAERS: 1US FAERS
475Meconium increasedFAERS: 1US FAERS
476MeningitisFAERS: 1US FAERS
477Mental FatigueFAERS: 1US FAERS
478Metabolic acidosisFAERS: 1US FAERS
479MetrorrhagiaFAERS: 1US FAERS
480Monocyte count increasedFAERS: 1US FAERS
481MonoplegiaFAERS: 1US FAERS
482Multiple System AtrophyFAERS: 1US FAERS
483Muscle FatigueFAERS: 1US FAERS
484Muscle SpasticityFAERS: 1US FAERS
485Musculoskeletal chest painFAERS: 1US FAERS
486MutismFAERS: 1US FAERS
487Myasthenia GravisFAERS: 1US FAERS
488MydriasisFAERS: 1US FAERS
489MyositisFAERS: 1US FAERS
490NephrolithiasisFAERS: 1US FAERS
491Nipple painFAERS: 1US FAERS
492No adverse eventFAERS: 1US FAERS
493NoduleFAERS: 1US FAERS
494Nonspecific reactionFAERS: 1US FAERS
495Obsessive-compulsive symptomFAERS: 1US FAERS
496Oral infectionFAERS: 1US FAERS
497OsteoporosisFAERS: 1US FAERS
498OverweightFAERS: 1US FAERS
499Pelvic venous thrombosisFAERS: 1US FAERS
500Penile InfectionFAERS: 1US FAERS
501Pharyngeal lesionFAERS: 1US FAERS
502Pharyngeal swellingFAERS: 1US FAERS
503Phobia of drivingFAERS: 1US FAERS
504PneumothoraxFAERS: 1US FAERS
505PolyuriaFAERS: 1US FAERS
506Poor feeding infantFAERS: 1US FAERS
507Poor sucking reflexFAERS: 1US FAERS
508Poor weight gain neonatalFAERS: 1US FAERS
509Pre-existing condition improvedFAERS: 1US FAERS
510Pregnancy test false positiveFAERS: 1US FAERS
511Pregnancy test negativeFAERS: 1US FAERS
512Premature MenopauseFAERS: 1US FAERS
513Premenstrual Dysphoric DisorderFAERS: 1US FAERS
514Product communication issueFAERS: 1US FAERS
515Product label confusionFAERS: 1US FAERS
516Product quality issueFAERS: 1US FAERS
517ProsopagnosiaFAERS: 1US FAERS
518Psychiatric evaluationFAERS: 1US FAERS
519Psychological TraumaFAERS: 1US FAERS
520Psychomotor skills impairedFAERS: 1US FAERS
521Psychotic disorder due to a general medical conditionFAERS: 1US FAERS
522Pulmonary toxicityFAERS: 1US FAERS
523PurpuraFAERS: 1US FAERS
524Pyloric StenosisFAERS: 1US FAERS
525Quality of life decreasedFAERS: 1US FAERS
526Rabbit syndromeFAERS: 1US FAERS
527Rebound psychosisFAERS: 1US FAERS
528RegurgitationFAERS: 1US FAERS
529Respiratory DepressionFAERS: 1US FAERS
530Respiratory FailureFAERS: 1US FAERS
531Respiratory distressFAERS: 1US FAERS
532School refusalFAERS: 1US FAERS
533Secretion dischargeFAERS: 1US FAERS
534Semen analysis abnormalFAERS: 1US FAERS
535Serotonin SyndromeFAERS: 1US FAERS
536Sinus headacheFAERS: 1US FAERS
537Sjogren's SyndromeFAERS: 1US FAERS
538Skin lacerationFAERS: 1US FAERS
539Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
540Sleep-related eating disorderFAERS: 1US FAERS
541Slow response to stimuliFAERS: 1US FAERS
542Slow speechFAERS: 1US FAERS
543SnoringFAERS: 1US FAERS
544Solar dermatitisFAERS: 1US FAERS
545Somatic symptom disorderFAERS: 1US FAERS
546StillbirthFAERS: 1US FAERS
547Sudden onset of sleepFAERS: 1US FAERS
548Suture ruptureFAERS: 1US FAERS
549SymphysiolysisFAERS: 1US FAERS
550T-Cell LymphomaFAERS: 1US FAERS
551Therapeutic product effect decreasedFAERS: 1US FAERS
552Therapy non-responderFAERS: 1US FAERS
553Therapy regimen changedFAERS: 1US FAERS
554Thermal burnFAERS: 1US FAERS
555Throat cancerFAERS: 1US FAERS
556Throat clearingFAERS: 1US FAERS
557Time perception alteredFAERS: 1US FAERS
558Tongue discomfortFAERS: 1US FAERS
559Tongue exfoliationFAERS: 1US FAERS
560Tonic clonic movementsFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
561Transcription medication errorFAERS: 1US FAERS
562TransplantFAERS: 1US FAERS
563TrichorrhexisFAERS: 1US FAERS
564TuberculosisFAERS: 1US FAERS
565Uterine contractions during pregnancyFAERS: 1US FAERS
566VasculitisFAERS: 1US FAERS
567Vocal Cord DysfunctionFAERS: 1US FAERS
568Vocal Cord ParalysisFAERS: 1US FAERS
569WheezingFAERS: 1US FAERS
570Wrong product administeredFAERS: 1US FAERS
571Wrong scheduleFAERS: 1US FAERS
572YawningFAERS: 1US FAERS
573furuncleFAERS: 1US FAERS
574jaundiceFAERS: 1US FAERS
575Anxiety Disorders20404009CTD
576Blood glucose fluctuationCanada Vigilance: 1Canada Vigilance
577Blood osmolarity increasedCanada Vigilance: 1Canada Vigilance
578Blood pH decreasedCanada Vigilance: 1Canada Vigilance
579Depressive disorder20404009CTD
580Psychoses, Substance-Induced20404009CTD
581Troponin increasedCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.